ArticleCureus2025
From the Unexpected: Unveiling the Diverse Presentations of Extraosseous Ewing's Sarcoma.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- Clinicopathologic correlates of Ewing (FET::ETS-rearranged) sarcoma and non-Ewing undifferentiated small round cell sarcomas across skeletal and extraskeletal sites.Frontiers in oncology · 2026Article
- Article
- Extraosseous Ewing's Sarcoma of the Chest Wall: A Case Report and Review of Literature.Cureus · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extraosseous Ewing's sarcoma (EES) is a rare but aggressive soft tissue malignancy of small round blue cells and commonly poses a diagnostic challenge because of its nonspecific anatomical locations and association with other neoplasms. This series of cases presents five uncommon presentations of EES in adult patients in the form of tumors present in the mediastinum, mesentery, right suprarenal gland, infraclavicular soft tissue, and prostate. The clinical presentations varied from rapidly worsening respiratory failure caused by a mediastinal tumor to a preoperatively misdiagnosed gastrointestinal stromal tumor that was subsequently diagnosed as EES post-surgery. Immunohistochemistry (IHC) was crucial in diagnosis, and all the cases were strongly positive for CD99 with supporting markers such as NKX2.2 and FLI-1. Multimodal treatment with chemotherapy (vincristine, doxorubicin (adriamycin), cyclophosphamide, ifosfamide, and etoposide (VDC-IE) regimen), surgery, and radiotherapy was used, and results were variable, with one patient dying of neutropenic sepsis and others having a favorable response to therapy with follow-up. This series puts forward the significance of keeping EES in the differential diagnosis of adult deep-seated or visceral soft tissue masses and the imperative need for prompt histopathological and immunohistochemical correlation to aid proper management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.